Interestingly, a recent whole exome sequencing study of AD patients has identified a protective genetic variant in a downstream substrate of BTK, PLCG2 (P522R) (Watanabe et al. 2001; Sims et al. 2017). Here, BTK is linked to Alzheimer disease.